Projects and Grants per year
- 1 - 50 out of 95 results
Search results
-
Active
Therapeutic Development Center FY25
Wurth, M. (PI), Anstead, M. (CoI), Autry, E. (CoI), Cosentino Roa, M. (CoI), Kanga, J. (CoI), Kormelink, L. (CoI) & Ramdial, F. (CoI)
7/1/24 → 6/30/25
Project: Research project
-
Cystic Fibrosis Center Program 2024-2025 (Adult Portion)
Anstead, M. (PI) & Fuller, W. (CoI)
7/1/24 → 6/30/25
Project: Research project
-
REACH-OB-23: A Research Study to Advance the CF Therapeutics Pipeline for People without Modulators
Wurth, M. (PI), Anstead, M. (CoI) & Cosentino Roa, M. (CoI)
Seattle Childrens Research Institute
6/1/24 → 5/31/26
Project: Research project
-
Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF (STRONG-CF)
Wurth, M. (PI) & Anstead, M. (CoI)
Jaeb Center for Health Research Foundation Incorporated
4/7/23 → 4/6/26
Project: Research project
-
A Phase 3, Open-Label Study Evaluating the Longterm Safety and Efficacy of VX-121 Combination Therapy in Subjects with Cystic Fibrosis
Wurth, M. (PI), Anstead, M. (CoI) & Danov, Z. (Former PI)
6/16/22 → 4/3/26
Project: Research project
-
A Prospective Study Evaluating Maternal and FetaL Outcomes in the ERa of ModulatorS (MAYFLOWERS)
Anstead, M. (PI), Kanga, J. (CoI) & Danov, Z. (Former CoI)
Seattle Childrens Research Institute
4/1/21 → 2/15/26
Project: Research project
-
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (The PROMISE Study)
Wurth, M. (PI), Anstead, M. (CoI) & Pancham, K. (Former PI)
Seattle Childrens Research Institute
11/1/18 → 6/14/25
Project: Research project
-
Finished
Cystic Fibrosis Center Program 2023-2024 (Adult Portion)
Anstead, M. (PI) & Fuller, W. (CoI)
7/1/23 → 6/30/24
Project: Research project
-
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF)
Wurth, M. (PI), Anstead, M. (CoI) & Danov, Z. (Former PI)
9/2/22 → 5/25/24
Project: Research project
-
Cystic Fibrosis Center Program 2022-2023 (Adult Portion)
Anstead, M. (PI) & Fuller, W. (CoI)
7/1/22 → 6/30/23
Project: Research project
-
Therapeutic Development Center FY24
Wurth, M. (PI), Anstead, M. (CoI), Kanga, J. (CoI), Kuhn, R. (CoI), Ramdial, F. (CoI) & Danov, Z. (Former CoI)
4/1/22 → 6/30/24
Project: Research project
-
Therapeutic Development Center FY23
Wurth, M. (PI), Anstead, M. (CoI), Danov, Z. (CoI), Kanga, J. (CoI) & Kuhn, R. (CoI)
4/1/22 → 3/31/23
Project: Research project
-
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for F508del or Heterozygous for F508del and a Gating (F/G) or Residual Function (F/R
Wurth, M. (PI), Anstead, M. (CoI), Garrett, N. (CoI) & Danov, Z. (Former PI)
9/1/21 → 5/25/24
Project: Research project
-
Cystic Fibrosis Center Program 2021-2022 (Adult Portion)
Anstead, M. (PI) & Fuller, W. (CoI)
7/1/21 → 6/30/22
Project: Research project
-
Cystic Fibrosis Care Center Program 2020-2021 (Adult Portion)
Anstead, M. (PI) & Fuller, W. (CoI)
7/1/20 → 6/30/21
Project: Research project
-
A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People with Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY)
Danov, Z. (PI), Anstead, M. (CoI), Garrett, N. (CoI), Wilson, E. (CoI) & Pancham, K. (Former CoI)
Seattle Childrens Research Institute
1/1/20 → 2/8/23
Project: Research project
-
VS18-445-113: A Phase 3, Open-label Study Evaluating the Long-term Safety of VX-445 Combination Therapy in Subjects with Cystic Fibrosis
Danov, Z. (PI), Anstead, M. (CoI) & Pancham, K. (Former PI)
7/22/19 → 5/27/23
Project: Research project
-
VX18-445-104: A Phase 3, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of VX-445 Comination Therapy in Subject with Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Gating or Residual Function Mutation
Danov, Z. (PI), Anstead, M. (CoI) & Pancham, K. (CoI)
7/8/19 → 6/18/21
Project: Research project
-
A Phase 2, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis
Pancham, K. (PI) & Anstead, M. (CoI)
3/14/19 → 1/29/21
Project: Research project
-
A Phase 2, Randomized, Double-blind, Controlled Study to Evaluate the Safety and Efficacy of VX-121 Combination Therapy in Subjects Aged 18 Years and Older with Cystic Fibrosis
Pancham, K. (PI) & Anstead, M. (CoI)
1/25/19 → 12/6/20
Project: Research project
-
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects with Cystic Fibrosis Who are Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF) VX17-659-102
Pancham, K. (PI) & Anstead, M. (CoI)
3/27/18 → 3/20/19
Project: Research project
-
A Real-World Chart Review Study on ORKAMBI Use in the United States
Anstead, M. (PI)
10/17/16 → 10/31/18
Project: Research project
-
Cystic Fibrosis Center Program 2016-2017
Kanga, J. (PI), Anstead, M. (CoI), Danov, Z. (CoI) & Pancham, K. (CoI)
7/1/16 → 6/30/17
Project: Research project
-
A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation
Anstead, M. (PI)
10/28/15 → 8/7/18
Project: Research project
-
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of N91115 to Evaluate Efficacy and Safety in Patients with Cystic Fibrosis who are Homozygous for the F508del-CFTR Mutation and Being Treated with lumacaftor/ivacaftor (ORKAMBI)
Anstead, M. (PI), Danov, Z. (CoI), Kanga, J. (CoI) & Tupayachi Ortiz, M. (CoI)
Nivalis Therapeutics Incorporated
9/30/15 → 8/30/17
Project: Research project
-
Cystic Fibrosis Center Program 2014-2015
Kanga, J. (PI) & Anstead, M. (CoI)
7/1/15 → 6/30/16
Project: Research project
-
A Phase 3, Randomized, Double-Blind, Ivacaftor-Controlled, Parellel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Comibayion with IVacaftor in Subjects Aged 12 years and Older with Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutaton
Anstead, M. (PI)
6/16/15 → 5/30/17
Project: Research project
-
CFFT TDN Spring Meeting
Anstead, M. (PI) & Danov, Z. (CoI)
Cystic Fibrosis Foundation Therapeutics Incorporated
2/1/15 → 7/31/15
Project: Research project
-
University of Kentucky ARC Award
Anstead, M. (PI)
Cystic Fibrosis Foundation Therapeutics Incorporated
12/1/14 → 11/30/15
Project: Research project
-
Additional Research Coordinator (ARC) Award
Anstead, M. (PI)
Cystic Fibrosis Foundation Therapeutics Incorporated
12/1/14 → 11/30/16
Project: Research project
-
Additional Research Coordinator (ARC) Award FY 17
Pancham, K. (PI) & Anstead, M. (CoI)
Cystic Fibrosis Foundation Therapeutics Incorporated
12/1/14 → 11/30/17
Project: Research project
-
Cystic Fibrosis Center Program--2014-2015
Kanga, J. (PI) & Anstead, M. (CoI)
7/1/14 → 6/30/15
Project: Research project
-
Therapeutics Development Network 2014-2015
Anstead, M. (PI), Danov, Z. (CoI), Kanga, J. (CoI) & Kuhn, R. (CoI)
Cystic Fibrosis Foundation Therapeutics Incorporated
1/1/14 → 12/31/15
Project: Research project
-
Therapeutic Development Center FY2020
Pancham, K. (PI), Anstead, M. (CoI), Danov, Z. (CoI), Kanga, J. (CoI) & Kuhn, R. (CoI)
1/1/14 → 3/31/20
Project: Research project
-
Therapeutic Development Center FY2021
Pancham, K. (PI), Anstead, M. (CoI), Danov, Z. (CoI), Kanga, J. (CoI) & Kuhn, R. (CoI)
1/1/14 → 3/31/21
Project: Research project
-
Therapeutic Development Center FY2022
Wurth, M. (PI), Anstead, M. (CoI), Danov, Z. (CoI), Kanga, J. (CoI) & Kuhn, R. (CoI)
1/1/14 → 3/30/22
Project: Research project
-
Therapeutic Development Center
Pancham, K. (PI), Anstead, M. (CoI), Danov, Z. (CoI) & Kuhn, R. (CoI)
Cystic Fibrosis Foundation Therapeutics Incorporated
1/1/14 → 12/31/17
Project: Research project
-
Therapeutics Development Center
Anstead, M. (PI), Danov, Z. (CoI), Kuhn, R. (CoI) & Tupayachi Ortiz, M. (CoI)
Cystic Fibrosis Foundation Therapeutics Incorporated
1/1/14 → 12/31/16
Project: Research project
-
Therapeutic Development Center FY 2018
Pancham, K. (PI), Anstead, M. (CoI), Danov, Z. (CoI) & Kuhn, R. (CoI)
1/1/14 → 12/31/18
Project: Research project
-
VX12-809-105 A Phase 3, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lu,acaftor in Combination With Ivacaftor in
Anstead, M. (PI)
12/4/13 → 1/31/16
Project: Research project
-
Vertex 770-115 An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 years of Age or Younger With Cystic Fibrosis
Anstead, M. (PI)
11/25/13 → 11/30/15
Project: Research project
-
Proof of Principal Evaluation of IV Gallium Nitrate (Ganite) in Patients with Cystic Fibrosis
Pancham, K. (PI), Danov, Z. (CoI), Kanga, J. (CoI), Anstead, M. (Former PI) & Tupayachi Ortiz, M. (Former PI)
Seattle Childrens Research Institute
9/1/13 → 6/30/18
Project: Research project
-
G551D Observational Study - Expanded to Additional Genotypes and TExtended for Long-term Follow-up
Anstead, M. (PI)
Seattle Childrens Research Institute
9/1/13 → 12/31/16
Project: Research project
-
Cystic Fibrosis Center Program 2019-2020 (Adult Portion)
Anstead, M. (PI)
7/1/13 → 6/30/20
Project: Research project
-
Cystic Fibrosis Center Program 2013-2014
Kanga, J. (PI) & Anstead, M. (CoI)
7/1/13 → 6/30/14
Project: Research project
-
Cystic Fibrosis Center Program 2017-2018
Kanga, J. (PI), Anstead, M. (CoI), Danov, Z. (CoI) & Pancham, K. (CoI)
7/1/13 → 6/30/18
Project: Research project
-
Cystic Fibrosis Center Program 2019-2020 (Adult Portion)
Anstead, M. (PI)
7/1/13 → 6/30/19
Project: Research project
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination with Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, omozygous for the F508del-CFTR Mutation
Anstead, M. (PI), Danov, Z. (CoI) & Kanga, J. (CoI)
6/20/13 → 6/30/15
Project: Research project
-
A phase 2, randomized, double blind, placebo-controlled study of AeroVanc for the treatment of persistent methicillin-resistant Staphylococcus aureus lung infection in cystic fibrosis patients (SAV005-02)
Danov, Z. (PI), Anstead, M. (CoI) & Kanga, J. (CoI)
3/13/13 → 3/31/15
Project: Research project
-
KaloBios CF KB001A-05 A Phase 2, Randomized Double-Blind, Placebo-Controlled, Repeat-dose Study of KB001A in Subjects with Cystic Fibrosis Infected withPseudomonas Aeruginosa
Danov, Z. (PI), Anstead, M. (CoI) & Kanga, J. (CoI)
KaloBios Pharmaceuticals Incorporated
10/30/12 → 10/30/14
Project: Research project